Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Mazzotta

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Panminerva Medica|May 14, 2021
The Progetto Ipertensione Umbria Monitoraggio Ambulatoriale (PIUMA) StudyPaolo Verdecchia, Giampaolo Reboldi, Giovanni Mazzotta, et al.
Current Vascular Pharmacology|July 15, 2010
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in the treatment of hypertension: should they be used together?Paolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, et al.
Vascular Health and Risk Management|February 3, 2009
The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reductionPaolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, et al.
Expert Opinion on Drug Safety|June 26, 2012
Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overviewFabio Angeli, Gianpaolo Reboldi, Giovanni Mazzotta, et al.
Expert Review of Clinical Pharmacology|November 26, 2011
Telmisartan for the reduction of cardiovascular morbidity and mortalityPaolo Verdecchia, Fabio Angeli, Giorgio Gentile, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 13, 2010
Angiotensin receptor blockers in hypertension. New insights from JapanPaolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, et al.
Giornale Italiano Di Cardiologia (2006)|April 21, 2020
[ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]Paolo Verdecchia, Gianpaolo Reboldi, Claudio Cavallini, et al.
Giornale Italiano Di Cardiologia (2006)|September 6, 2024
[Secondary hypertension: diagnosis and treatment]Paolo Verdecchia, Gianpaolo Reboldi, Giovanni Mazzotta, et al.
Vascular Health and Risk Management|December 10, 2009
Comparative assessment of angiotensin receptor blockers in different clinical settingsPaolo Verdecchia, Fabio Angeli, Salvatore Repaci, et al.
Obstetrics and Gynecology|March 24, 2010
Neutrophil count for the identification of postmenopausal hypertensive women at increased cardiovascular riskFabio Angeli, Enrica Angeli, Giuseppe Ambrosio, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Panminerva Medica|May 14, 2021
The Progetto Ipertensione Umbria Monitoraggio Ambulatoriale (PIUMA) StudyPaolo Verdecchia, Giampaolo Reboldi, Giovanni Mazzotta, et al.
Current Vascular Pharmacology|July 15, 2010
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in the treatment of hypertension: should they be used together?Paolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, et al.
Vascular Health and Risk Management|February 3, 2009
The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reductionPaolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, et al.
Expert Opinion on Drug Safety|June 26, 2012
Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overviewFabio Angeli, Gianpaolo Reboldi, Giovanni Mazzotta, et al.
Expert Review of Clinical Pharmacology|November 26, 2011
Telmisartan for the reduction of cardiovascular morbidity and mortalityPaolo Verdecchia, Fabio Angeli, Giorgio Gentile, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 13, 2010
Angiotensin receptor blockers in hypertension. New insights from JapanPaolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, et al.
Giornale Italiano Di Cardiologia (2006)|April 21, 2020
[ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]Paolo Verdecchia, Gianpaolo Reboldi, Claudio Cavallini, et al.
Giornale Italiano Di Cardiologia (2006)|September 6, 2024
[Secondary hypertension: diagnosis and treatment]Paolo Verdecchia, Gianpaolo Reboldi, Giovanni Mazzotta, et al.
Vascular Health and Risk Management|December 10, 2009
Comparative assessment of angiotensin receptor blockers in different clinical settingsPaolo Verdecchia, Fabio Angeli, Salvatore Repaci, et al.
Obstetrics and Gynecology|March 24, 2010
Neutrophil count for the identification of postmenopausal hypertensive women at increased cardiovascular riskFabio Angeli, Enrica Angeli, Giuseppe Ambrosio, et al.
Pageof 6